Interstitial single fraction brachytherapy for malignant pulmonary tumours
ConclusionsInterstitial brachytherapy for pulmonary tumours is a highly conformal therapy with minimal doses to the organs at risk. For the majority of patients, treatment can be performed without relevant complications in a single fraction with a satisfactory local control.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research
More News: Bleeding | Brachytherapy | Cancer | Cancer & Oncology | Cardiology | Colorectal Cancer | Esophagus Cancer | Heart | Lung Cancer | Non-Small Cell Lung Cancer | Oesophagus | Pneumothorax | Study | Toxicology